Clinical Trial: Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study Type: INTERVENTIONAL
Official Title: Pilot Trial to Investigate Immune Response to an Extended Course of Sipuleucel-T Immunotherapy in Patients With Metastatic Castration-resistant Prostate Cancer (OU-SCC-EXCITE)
Brief Summary:
Proposed immunotherapy with an extended course of Sipuleucel-T treatment may induce a more robust immune response and improve the anti-cancer efficacy of Sipuleucel-T in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC).
Read more